Leaflet LISDEXAMFETAMINA ADALVO 60mg capsules

Indicated for: attention deficit hyperactivity disorder (ADHD)

Route of administration: oral

Substance: lisdexamfetamine (psychostimulant)

ATC: N06BA12 (Nervous system | Psychostimulants, agents used for adhd and nootropics | Centrally acting sympathomimetics)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse
Dependence / abuse

This medicine may cause dependence or be misused.

Seizure risk
Seizure risk

This medicine may increase the risk of seizures.

Lisdexamfetamine is a medication primarily used to treat attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It is also approved for the treatment of binge eating disorder in adults. It is a prodrug, meaning it becomes active only after being metabolized in the body, converting into dextroamphetamine, a central nervous system stimulant.

Lisdexamfetamine works by increasing levels of dopamine and norepinephrine in the brain, neurotransmitters involved in regulating attention, impulse control, and motor activity. Through this mechanism, the medication helps improve focus, reduce hyperactivity, and control impulsive behavior.

The medication is taken as capsules or chewable tablets, usually once daily in the morning. The dose is adjusted by the doctor based on the patient’s response and tolerance. It is important to take the medication as prescribed to avoid side effects or the risk of misuse.

Common side effects include insomnia, weight loss, decreased appetite, dry mouth, anxiety, or irritability. In rare cases, more serious adverse effects such as increased blood pressure, tachycardia, or psychiatric symptoms (e.g., hallucinations) may occur. Patients should inform their doctor of any unusual symptoms.

Lisdexamfetamine is contraindicated in patients with severe cardiovascular disease, uncontrolled hypertension, hyperthyroidism, or a history of substance abuse. It is essential for the treatment to be monitored by a doctor, and patients should avoid taking the medication in the evening to prevent insomnia.

General data about LISDEXAMFETAMINA ADALVO 60mg

  • Substance: lisdexamfetamine
  • Date of latest medicines list: 01-12-2023
  • Product code: W69468001
  • Concentration: 60mg
  • Pharmaceutical form: capsules
  • Quantity: 30
  • Product type: Generic medicine
  • Prescription status: TAB2 - Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.

Marketing authorisation

  • Manufacturer: PHARMADOX HEALTHCARE LIMITED - MALTA
  • Holder: ADALVO LIMITED - MALTA
  • Number: 14911/2023/01
  • Shelf life: 2 years

Concentrations available for lisdexamfetamine

  • 20mg
  • 30mg
  • 40mg
  • 50mg
  • 60mg
  • 70mg